52 results
DEFM14A
ENZ
Enzo Biochem, Inc.
24 Apr 23
Proxy related to merger
4:01pm
targets or arrangements currently in place for 2023 (including bonus target, incentive compensation target, deferred compensation, and commissions
PREM14A
ENZ
Enzo Biochem, Inc.
12 Apr 23
Preliminary proxy related to merger
8:49pm
or other rate of base pay, if applicable, (vii) other compensation targets or arrangements currently in place for 2023 (including bonus target, incentive
8-K
EX-99.2
13qidbkz2laln2c
17 Dec 20
Regulation FD Disclosure
12:43pm
DEFA14A
pivi1sm78o4p8z0u3iju
31 Dec 19
Additional proxy soliciting materials
5:30pm
DEFC14A
3vaqtucaxp8682r4
5 Dec 19
Proxy in contested solicitation
4:22pm
PREC14A
jugeuygshwd860l84v
20 Nov 19
Preliminary proxy with contested solicitation
5:26pm
8-K
EX-99.1
j0f goc5upzb0e
15 Oct 19
Enzo Biochem Reports Fiscal Fourth Quarter and Full Year Financial Results
4:43pm
8-K
EX-99.1
y0y4e3001q fav
5 Aug 19
Other Events
4:05pm
8-K
EX-99.1
1lpde
13 May 19
Enzo Biochem Inc. Announces Issuance of United States Patent for Treatment of Liver Cancer Using Ozanimod
4:58pm